Jose C. Bisneto

Hematology

200 1st St SW
Rochester, MN 55905

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Optimizing low dose radiotherapy for indolent lymphomas: comparing 8 Gy in 2 fractions to 4 Gy in 2 fractions.

Optimizing low dose radiotherapy for indolent lymphomas: comparing 8 Gy in 2 fractions to 4 Gy in 2 fractions.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: January 13, 2026

The ratio of brain to liver glucose activity and prognosis with CAR-T in non-Hodgkin lymphoma.

The ratio of brain to liver glucose activity and prognosis with CAR-T in non-Hodgkin lymphoma.

Journal: Blood cancer journal

Published: August 18, 2025

Incidental vs. symptomatic diagnosis of follicular lymphoma: implications of earlier detection.

Incidental vs. symptomatic diagnosis of follicular lymphoma: implications of earlier detection.

Journal: Blood cancer journal

Published: March 31, 2025

Hypomagnesemia in lymphoma patients receiving CAR T therapy correlates with immune dysfunction and decreased survival.

Hypomagnesemia in lymphoma patients receiving CAR T therapy correlates with immune dysfunction and decreased survival.

Journal: Experimental hematology & oncology

Published: December 27, 2024

Outcomes and molecular profiles in sarcomatoid carcinoma of unknown primary: the Mayo Clinic experience.

Outcomes and molecular profiles in sarcomatoid carcinoma of unknown primary: the Mayo Clinic experience.

Journal: The oncologist

Published: July 19, 2024

Real-world associations of cytokine release syndrome and neurotoxicity with efficacy in patients receiving anti-CD-19 chimeric antigen receptor T-cell therapy for large B-cell lymphoma: the Mayo Clinic experience.

Real-world associations of cytokine release syndrome and neurotoxicity with efficacy in patients receiving anti-CD-19 chimeric antigen receptor T-cell therapy for large B-cell lymphoma: the Mayo Clinic experience.

Journal: Leukemia & lymphoma

Published: November 30, 2023

Efficacy of checkpoint inhibition after CAR-T failure in aggressive B-cell lymphomas: outcomes from 15 US institutions.

Efficacy of checkpoint inhibition after CAR-T failure in aggressive B-cell lymphomas: outcomes from 15 US institutions.

Journal: Blood advances

Published: February 17, 2023

CAR-T Therapy in Lymphoma Patients With Coexisting Cardiomyopathy or Cardiac Lymphomatous Involvement.

CAR-T Therapy in Lymphoma Patients With Coexisting Cardiomyopathy or Cardiac Lymphomatous Involvement.

Journal: JACC. Case reports

Published: January 24, 2023

Follicular lymphoma B cells exhibit heterogeneous transcriptional states with associated somatic alterations and tumor microenvironments.

Follicular lymphoma B cells exhibit heterogeneous transcriptional states with associated somatic alterations and tumor microenvironments.

Journal: Cell reports. Medicine

Published: September 16, 2022

Metabolic characteristics and prognostic differentiation of aggressive lymphoma using one-month post-CAR-T FDG PET/CT.

Metabolic characteristics and prognostic differentiation of aggressive lymphoma using one-month post-CAR-T FDG PET/CT.

Journal: Journal of hematology & oncology

Published: February 10, 2022

Uncovering Pharmacological Opportunities for Cancer Stem Cells-A Systems Biology View.

Uncovering Pharmacological Opportunities for Cancer Stem Cells-A Systems Biology View.

Journal: Frontiers in cell and developmental biology

Published: August 02, 2021

Characteristics of late transplant-associated thrombotic microangiopathy in patients who underwent allogeneic hematopoietic stem cell transplantation.

Characteristics of late transplant-associated thrombotic microangiopathy in patients who underwent allogeneic hematopoietic stem cell transplantation.

Journal: American journal of hematology

Published: May 12, 2020

Showing 1-12 of 19

Last Updated: 09/26/2026